Pype AI

Pype AI, based in the United States, delivers advanced AI-driven solutions for automating patient communications, significantly enhancing efficiency in healthcare operations. Founded in 2024, Pype AI specializes in automating patient communications through innovative AI voice agent technology. The company is headquartered in San Francisco, US. In November 2025, Pype AI raised USD 1.

2 mn in pre-seed funding led by Kalaari Capital, with participation from WYSER and Tenity. The total amount raised by the company is USD 1. 2 mn. The firm's operations have been focused on enhancing healthcare communication processes.

Pype AI specializes in automating patient communications through its AI voice agent technology, designed to enhance operational efficiency within healthcare settings. The core offerings include automated scheduling, appointment reminders, medication adherence notifications, and various follow-up communications such as pre-procedure instructions and billing reminders. These services aim to reduce no-show rates, minimize administrative burdens, and allow healthcare providers to efficiently manage patient inquiries without increasing contact center workloads. Pype serves a diverse client base that includes hospitals and healthcare organizations, notably in the United States and other regions actively adopting AI-driven solutions in the healthcare sector.

The AI voice agents are designed to seamlessly integrate with existing healthcare tools and systems, ensuring compliance with HIPAA regulations and data privacy requirements. Pype's revenue model is based on subscription services, where healthcare organizations pay for access to its AI voice agent technology. Transactions typically involve contractual agreements where hospitals subscribe to a service plan encompassing a suite of automated communication tools tailored to their specific needs. Pricing structures may vary based on call volume, range of services utilized, and level of integration with existing electronic medical record (EMR) or electronic health record (EHR) systems.

This model allows healthcare providers to scale their use of Pype's services according to their patient load and operational requirements. In November 2025, Pype AI plans to utilize the USD 1. 2 mn raised in pre-seed funding to enhance its research-based communication platform and expand its operations in the US. The company is focusing on developing new products aimed at improving patient engagement and communication efficiency, with targeted releases planned in the near future.

Additionally, Pype AI is exploring opportunities for growth in other healthcare markets that are increasingly adopting AI technologies.